Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NIH awards Celsion grant to develop new oncology treatments

Sep. 3, 2010

Agensys initiates phase I trial of AGS-16M8F in renal cancer

Sep. 2, 2010

Ono receives exclusive rights in Japan to salirasib

Sep. 2, 2010

Celator achieves funding for CPX-351 trials in AML

Sep. 2, 2010

New PKB inhibitors presented by GlaxoSmithKline

Sep. 2, 2010

Bayer Schering Pharma identifies new Akt inhibitors

Sep. 2, 2010

Celgene discovers new isotopologues of lenalidomide

Sep. 1, 2010

Phase II and III trials examine SIR-Spheres in patients with refractory colorectal liver metastases

Sep. 1, 2010

Yissum claims new MMP-2 inhibitors

Sep. 1, 2010

Patient recruitment begins for phase II MK-2206 trial in colorectal cancer

Aug. 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...